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Simple Summary: The problem addressed in this research was the possibility of enhancing the
nutritional value and health beneficial omega-3 long-chain fatty acid content of lamb and its edible
components. The aims and objectives were to evaluate the omega-3 contents of muscle, liver, kidney,
and heart of lot-fed Tattykeel Australian White lambs of the MARGRA brand, in response to dietary
supplementation with or without omega-3 oil fortified pellets. The findings demonstrate that the
inclusion of omega-3 oil in feedlot diets of lambs enhances the human health beneficial omega-3 long-
chain polyunsaturated fatty acid profiles of edible muscle tissue and organs without compromising
meat quality or shelf life. These results are valuable to society because of increased functionality,
health benefits, micro-marbling, tender, mouth-melting taste, and high-end eating quality experience
of MARGRA lamb tissues and organs.
Abstract: The aim of this research was to evaluate the nutritional enhancement of omega-3 long-
chain polyunsaturated fatty acid (n-3 LC-PUFA) composition of edible lamb Longissimus thoracis et
lumborum muscle, heart, kidney, and liver in response to dietary supplementation of lot-fed lambs
with or without omega-3 oil fortified pellets. The hypothesis tested was that fortifying feedlot
pellets with omega-3 oil will enhance the human health beneficial n-3 LC-PUFA composition of
edible lamb muscle tissue and organs. Seventy-five Tattykeel Australian White lambs exclusive to
the MARGRA brand, with an average body weight of 30 kg at six months of age, were randomly
assigned to the following three dietary treatments of 25 lambs each, and lot-fed as a cohort for
47 days in a completely randomized experimental design: (1) Control grain pellets without oil
plus hay; (2) Omega-3 oil fortified grain pellets plus hay; and (3) Commercial whole grain pellets
plus hay. All lambs had ad libitum access to the basal hay diet and water. Post-slaughter fatty acid
composition of the Longissimus thoracis et lumborum muscle, liver, kidney, and heart were determined
using thee gas chromatography–mass spectrophotometry technique. Results indicated significant
variations (p < 0.05) in fatty acid profiles between tissues and organs. Omega-3 oil fortified pellets
significantly (p < 0.05) increased ≥C20 n-3 LC-PUFA (C20:5n-3 eicosapentaenoate, EPA + C22:5n3
docosapentaenoate, DPA + C22:6n3 docosahexanoate DHA); C18:3n-3 alpha-linolenate, ALA; C18:2
conjugated linoleic acid, CLA; total monounsaturated fatty acids, MUFA; polyunsaturated fatty acids,
PUFA contents; and reduced the ratio of omega-6 to omega-3 fatty acids in all lamb organs and
tissues without impacting shelf-life. The findings demonstrate that the inclusion of omega-3 oil in
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feedlot diets of lambs enhances the human health beneficial omega-3 long-chain polyunsaturated
fatty acid profiles of edible muscle tissue and organs without compromising meat quality.
Keywords: MARGRA lamb; omega-3 fatty acids; Longissimus thoracis et lumborum muscle; kidney;
heart; liver; meat quality; oil; whole grain
1. Introduction
Functional foods are among the fastest-growing markets in developed countries
where the average consumer prefers omega-3 enrichment with information about the
food’s production process [1]. Functional foods can influence satiety and a healthier
lifestyle [2]. The main strategies for creating healthier and functional foods with increased
satiety include the modification of dietary fat, fiber, and sugar compositions [2]. Ansorena
and Astiasarán [3] provided insights into the methods of modifying the formulations
of fresh, cooked, and fermented meat products in order to increase omega-3 fatty acid
content without modifying animal diets. The fortification of functional beef burgers with
microencapsulated cod liver oil [4], algal and wheat germ oil emulsions [5] are examples of
methods for enriching foods with omega-3 fatty acids.
The demand for high quality meat is on the increase as consumer preferences for
edible animal-based protein sources shift toward eating quality with increased human
health benefits. Meat, an essential component of the human diet, is rich in nutrients
including protein, fatty acids, iron, zinc, copper, selenium, and B-complex vitamins [6–8].
Omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) are essential fatty acids
that play diverse roles in human health and disease prevention. They include the following
longer chain derivatives of alpha-linolenic acid (ALA, C18:3n-3): Eicosapentaenoic (EPA,
C20:5n-3), docosapentaenoic (DPA, C22:5n-3), and docosahexaenoic (DHA, C22:6n-3) acids.
EPA + DPA + DHA are known to promote intellectual development in infancy, relieve
inflammation, boost the immune system, reduce incidences of cardiovascular diseases,
some cancers, diabetes, allergies, behavioral disorders, and sustain retinal functions [9–12].
However, humans, like all mammals, cannot synthesize n-3 LC-PUFA because they are
unable to produce ∆12 and ∆15-desaturase enzymes [13], hence, rely on dietary sources like
leafy vegetables, oilseeds, nuts, eggs, and seafood, especially fish and crustaceans [10,14],
edible marine algae, bacteria, fungi, diatoms, fruits, and herbs [15], to meet their daily n-3
LC-PUFA requirements. Oilseeds commonly used in human diets include rapeseed [16]
and soybean [17], while seed oils from waste food by-products such as tomato [18] and
citrus [19] are cheap animal feed sources that can enhance healthy fatty acid composition.
Fatty acid composition influences the nutritive value and organoleptic traits of meat
including tenderness, flavor, and juiciness [20]. The fatty acid content of meat can be
affected by the animal production system [21,22], breed or genotype [23,24], gender [25],
age at slaughter [26], liveweight [27], level of fatness [20], type of muscle and feed. In
lamb [28], cattle, swine, and poultry [29], it has been suggested that dietary manipula-
tion can be utilized to improve the fatty acid content and nutritional value of meat that
more closely meets nutritional guidelines. However, due to extensive rumen microbial
biohydrogenation in ruminants, dietary polyunsaturated fatty acids (PUFA) are converted
to saturated fatty acids (SFA), absorbed in the small intestine, and deposited in edible
tissues (muscles), products (milk), and organs (liver, kidney and heart), thereby causing
more health challenges to consumers [30,31]. Ruminant meat research is aimed at reducing
saturated fatty acids and increasing the proportion of health-beneficial n-3 LC-PUFA [31].
Therefore, dietary supplementation with rumen-protected plant and fish-based n-3 LC-
PUFA oil, forages, and concentrates containing bioactively enriched microalgae [32] are
some of the steps taken by livestock farmers to improve the nutritional and health values
of meat.
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To the current knowledge of the authors of this research, there is presently no pub-
lished literature on n-3 LC-PUFA metabolism in the Longissimus thoracis et lumborum muscle,
heart, kidney, and liver of lot-fed Tattykeel Australian White (TAW) MARGRA lambs in re-
sponse to dietary supplementation with omega-3 oil. The research reported in this present
study intends to fill this knowledge gap. It was hypothesized that fortifying feedlot pellets
with omega-3 oil will enhance the human health beneficial n-3 LC-PUFA composition of edible lamb
muscle tissue and organs. Therefore, the primary objective of this study was to evaluate and
compare the fatty acid profiles in the tissues and organs of TAW lambs raised in a feedlot
production system in response to dietary supplementation with or without fortification
with omega-3 oil.
2. Materials and Methods
2.1. Animals, Dietary Treatments, and Experimental Design
This lamb finishing feeding trial was conducted at the Crown Agriculture’s feedlot fa-
cility at Borenore, New South Wales, Australia, from April to June 2019. Borenore is located
at latitude 33◦19′S and longitude 149◦04′E with an elevation of 3024 feet above sea level
and average annual temperature of 11.7 ◦C (53.0 ◦F) and rainfall of 939.8 mm (37.0 inches).
The feedlot was an automated facility in a well-ventilated covered building with concrete
floors, density of five square meters per head with all the feeding troughs equipped with
installed sensors capable of immediate data capture of each lamb’s ear tag identification,
entry and exit times, body weight, feed intake, and other vital parameters. These data
are automatically recorded, electronically cloud-stored, and directly downloadable into
Excel spreadsheets and transmitted when required. Seventy-five Tattykeel Australian
White lambs exclusive to the MARGRA brand, with an average body weight of 30 kg at
six months of age, were randomly assigned to the following three dietary treatments of
25 lambs each, and lot-fed as a cohort for 47 days after a 14-day adaptation period in a
completely randomized experimental design: (1) Control grain pellets without oil plus
hay; (2) omega-3 oil fortified grain pellets plus hay; and (3) commercial whole grain pellets
plus hay. All lambs had ad libitum access to the basal hay diet and water. The nutrient
composition of the supplementary and basal diets is presented in Table 1.
Table 1. Nutrient composition of the control, n-3 LC PUFA, MSM whole grain, and hay feeds #.
Nutrient Composition (%DM)
Experimental and Basal Diets
Control Omega-3 MSM Whole Grain Hay
Dry Matter (DM) 90.8 91.7 90.3 93.4
Moisture 9.2 8.3 9.7 6.6
Acid Detergent Fiber (ADF) 7.6 8.2 6.3 39.4
Neutral Detergent Fiber (NDF) 23.8 23.0 21.8 60.9
Crude Protein (CP) 16.9 17.0 16.4 7.5
Ash 7.8 8.2 7.2 8.1
Ether Extract (EE) 6.1 10.3 6.0 3.3
Metabolizable Energy (ME) MJ/kg 14.1 15.1 14.4 8.3
Dry Matter Digestibility (DMD) 84.9 83.8 87.5 46.8
Digestible Organic Matter (DOMD) 83.7 82.6 86.2 47.1
# DOMD, Digestible organic matter in the dry matter; TDN, %Total digestible nutrients (as % of DM) = 82.38 − (0.7515 × ADF [%
of DM]); ME, Metabolizable energy (DE [Mcal/kg] = %TDN × 0.01 × 4.4) where DE is digestible energy, which was converted as
ME = (DE (Mcal/kg) × 0.82) × 4.185.
At the end of the feeding trial, the lambs were conveyed during the cool hours of the
day to the Gundagai Meat Processing Plant, New South Wales, Australia, held in lairage
and fasted overnight. The lambs were humanely sacrificed as a single mob in line with Meat
Standards Australia guidelines and industry best practice standards. The carcasses were
subjected to medium voltage electrical stimulation before being trimmed and dressed [33].
The liver, kidney, and heart were sampled immediately following evisceration, vacuum-
sealed in labelled bags, and stored at −20 ◦C pending fatty acid evaluation. All carcasses
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were held in the chiller room for 24 h at 4 ◦C and a sample of the Longissimus thoracis et
lumborum muscle tissue was taken between the 12th and 13th ribs for fatty acid analysis.
2.2. Feed Sample Processing and Nutrient Composition Analysis
Supplementary and basal feed samples were oven-dried for three days at 60 ◦C,
cooled, and ground to pass through a 1 mm sieve using a laboratory mill (Thomas Model 4
Wiley® Mill; Thomas Scientific, Swedesboro, NJ, USA). Dry matter and ash percentages
were determined using the AOAC standard laboratory analytical techniques [34]. Neutral
detergent (NDF) and acid detergent (ADF) fiber percentages were determined using an
Ankom Fiber Analyzer (ANKOM2000; ANKOM Technology, Macedon, NY, USA). Nitrogen
content was determined using a Thermo Finnigan EA 1112 Series Flash Elemental Analyzer
(Thermo Finnigan, Poway, CA, USA) and the values were multiplied by 6.25 to provide the
expected crude protein (CP) percentage. Ether extract (EE) was analyzed employing an
ANKOMXT15 fat/oil extractor (ANKOM Technology, Macedon, NY, USA).
2.3. Fatty Acid Analysis
Fatty acid analysis of feed, muscle tissue, liver, kidney, and heart samples was carried
out at the Commonwealth Scientific and Industrial Research Organization (CSIRO), Food
Nutrition and Bio-based Products, Oceans and Atmosphere Laboratory, Hobart, Tasma-
nia, Australia. The gas chromatography–mass spectrophotometry total lipids and muscle
phospholipids extraction procedures of Malau-Aduli et al. [35,36] based on an amended
Bligh and Dyer technique [37], were utilized for fatty acid composition analysis where
total lipids in 1 g of un-homogenized muscle tissue samples were extracted overnight. The
original phase was a single-phase overnight extraction utilizing CHCl3:MeOH:H2O (1:2:0.8
v/v). The second segment involved phase separation with the addition of CHCl3:saline
Milli-Q H2O (1:1 v/v) followed by rotary evaporation of the lower chloroform phase at
40 ◦C to acquire total lipids. The extracted cumulative lipids were separated into lipid
classes by thin-layer chromatography (TLC) using 100 mL of the lipid extract reconstituted
in n-hexane. The extract was marked onto silica gel G plates (200 × 200 × 0.25 mm3) using
a micropipette. The TLC plate was developed in an acetone/petroleum ether (1:3 vol/vol)
solvent system in a tank comprising a few crystals of butylated hydroxytoluene (BHT)
to hinder oxidation. Triacylglycerols, cholesterol, and free fatty acids migrated, while
phospholipids remained at the origin of the plate. The phospholipids were scraped off the
plate into clean screw-capped test tubes for transmethylation and eventual computation of
the lipid conversion factor (LCF) of 0.912 based on g fatty acids/g total lipids (0.083 for
phospholipids, 0.829 for triacylglycerols, and 0% for cholesterol since cholesterol does not
have any fatty acids). An aliquot from each total lipid extract was utilized for transmethy-
lation with MeOH:CHCl3:HCl (10:1:1 v/v) for two hours at 80 ◦C. Fatty acid methyl esters
(FAME) were extracted thrice using n-hexane:CHCl3 (4:1 v/v). A known concentration
of an internal standard (C19:0) was added in a 1500 µL vial encompassing the extracted
FAME. The FAME was analyzed on a 7890B gas chromatograph (Agilent Technologies,
Palo Alto, CA, USA) furnished with an EquityTM -1 fused 15 m silica capillary column
with 0.1 mm internal diameter and 0.1 µm film thickness (Supelco, Bellefonte, PA, USA),
a flame ionization sensor, a split/splitless injector, and an Agilent Technologies 7683 B
Series autosampler. The gas chromatograph settings were splitless mode injection; carrier
gas He; original oven temperature 120 ◦C and then increased to 270 ◦C at flow rates of
10 ◦C/min and to 310 ◦C at 5 ◦C/min. The Agilent Technologies ChemStation software
(Palo Alto, CA, USA) was used to measure fatty acid peaks. The fatty acid identities were
established using a Finnigan Thermoquest GCQTM GC/MS fitted with an on-column
injector and Thermoquest Xcalibur software (Austin, TX, USA) as described in detail by
Miller et al. [38]. Fatty acid percentages were calculated as follows: FA% = [(individual
fatty acid area) × (100)]/(sum total area of fatty acids). Fatty acid contents were calculated
as follows: FA mg/100 g = (Total lipid) × (LCF [0.912]) × ([%FA]/100) × 1000, where 0.912
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was the resultant lipid conversion factor [39]. FA contents were presented in mg/100 g
tissue as per Food Standards of Australia and New Zealand recommendations.
2.4. Statistical Analyses
Data analysis was performed as a completely randomized design using R statistical
software version 3.6.3 [40]. Statistical inference was based on a 5% level of significance.
Summary statistics of fatty acids composition were presented as means and standard
deviations. The effect of dietary treatment was statistically analyzed separately using
one-way analysis of variance (ANOVA) in the general linear model (GLM) procedure to
investigate the fatty acid profile differences in the muscle, liver, kidney, and heart of the
TAW lambs.
The model utilized was:
FAij = µ + Feedi + εij
where FA is the fatty acid composition; µ is the overall mean response; Feedi is the effect due
to the ith treatment (i = 1 to 3; control, omega-3, MSM whole grain); and εij is the random
error. Dunn’s post-hoc test [41,42] for multiple comparisons of groups with Hochberg’s
adjustment [43,44] was used to further examine which treatment was responsible for
the differences among means of fatty acids that were statistically significant in the one-
way ANOVA.
3. Results
3.1. Fatty Acid Composition of Basal and Supplementary Feeds
The fatty acid profiles of the basal (hay), control (without oil), omega-3 oil-fortified
(omega-3), and whole grain (MSM) pelleted diets are shown in Table 2. All the supple-
mentary diets were formulated to be isocaloric (metabolizable energy of 14–15 MJ/kg) and
isonitrogenous (crude protein of 16.4–17.0%) with a dry matter digestibility of 83.8–87.5%.
As depicted in Table 1, the omega-3 oil-infused diet had higher EPA + DHA + DPA, n-3
LC-PUFA and ALA (2.74, 19.18, and 15.39 mg/100 g, respectively), and lower total n-6
PUFA and ratios of n-6/n-3 and PUFA/SFA (28.16, 1.47, and 0.75 mg/100 g, respectively)
than the control and MSM whole grain diets. The MSM whole grain diet had the highest
proportions of C18:2n-6 (linoleic acid) and oleic acid (C18:1) (92.38 and 75.06 mg/100 g,
respectively). The control diet had a higher n-6/n-3 ratio value of 9.08, while the basal hay
diet had the highest proportion of C20:2n-6 and C20:4n-6 (arachidonic acid).
3.2. Fatty Acid Profile of the Longissimus thoracis et lumborum Muscle
The fatty acid composition of the longissimus thoracis et lumborum muscle tissue is
presented in Table 3. The omega-3 oil diet produced lamb muscles with the highest
contents of n-3 LC-PUFA, DHA, EPA, DPA, C18:3n-3, C18:1, C18:0 (stearic acid), total
SFA, MUFA, and PUFA/SFA ratio. The MSM whole grain diet produced muscles with
the highest n-6/n-3 PUFA ratio. A boxplot of Hochberg’s adjusted multiple comparisons
of significant differences between the treatment groups in muscle fatty acid profiles are
depicted in Figure 1, where the omega-3 diet consistently shows a significantly higher fatty
acid concentration than the control and MSM whole grain diets.
3.3. Fatty Acid Content of Liver
In the liver (Table 4), it was evident that the sheer volume of total fatty acid metabolism
output was greater than in the muscle, kidney, and heart. The omega-3 oil diet had
significantly higher CLA (p < 0.0346), EPA + DHA (p < 0.0000), EPA + DHA + DPA
(p < 0.0002), PUFA/SFA (p < 0.0365), n-3 LC-PUFA (p < 0.0004), n-6 PUFA (p < 0.0008), and
n-6/n-3 PUFA ratio (p < 0.0000) than the other treatment groups. A boxplot of Hochberg’s
adjusted multiple comparisons of significant differences between the treatment groups in
liver fatty acid profiles are depicted in Figure 2, where the omega-3 oil diet maintained
a significantly higher fatty acid content than the control and MSM whole grain diets.
However, the compositions of C14:0, C17:1n8c + a17:0, C18:3n-6, C19:1, C20:4n-6, C20:3,
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CLA, C22:5n-6, C22:4n-6, C23:0, n-6 PUFA, and n-6/n-3 PUFA ratio in the MSM whole
grain diet were higher than in the control and omega-3 oil diets.
Table 2. Fatty acid composition (mg/100 g) of basal and supplementary diets #.
Fatty Acid Omega-3 Control MSM Whole Grain Basal Hay
13:0 0.00 0.00 0.01 0.00
14:1 0.00 0.00 0.00 0.00
14:0 2.23 0.45 0.25 0.33
15:0 2.62 0.36 0.30 0.21
16:1 1.02 0.79 1.05 1.88
16:0 35.96 27.19 30.52 12.53
17:1n8c + a17:0 0.64 0.27 0.25 0.18
17:0 1.09 0.33 0.30 0.13
18:3n6 0.32 0.00 0.00 0.24
18:4n3 0.32 0.00 0.00 0.20
18:2n6 (LA) 25.25 81.75 92.38 30.02
18:3n3 (ALA) 15.39 8.84 11.21 6.13
CLA 0.65 0.10 0.29 0.00
18:0 8.25 4.59 4.13 2.74
18:1 31.92 57.34 75.06 51.23
19:1 0.00 0.04 0.06 0.04
20:4n6 (ARA) 0.00 0.00 0.00 0.53
20:5n3 (EPA) 0.22 0.18 0.23 0.00
20:3 0.00 0.00 0.01 0.00
20:3n6 0.80 0.15 0.16 0.18
20:4n3 0.30 0.00 0.00 0.02
20:2n6 0.32 0.13 0.21 0.33
20:1 1.51 1.71 2.02 1.79
20:0 2.80 0.60 0.81 0.42
21:5n3 0.43 0.00 0.00 0.00
21:0 1.17 0.16 0.08 0.00
22:5n6 0.87 0.01 0.08 0.00
22:6n3 (DHA) 1.53 0.03 0.05 0.93
22:4n6 0.60 0.08 0.05 0.00
22:5n3 (DPA) 0.99 0.00 0.17 0.22
22:1 2.39 0.47 0.34 0.25
22:0 4.63 0.44 0.60 0.23
23:1 0.64 0.06 0.00 0.00
23:0 1.72 0.01 0.14 0.02
24:1 0.94 0.25 0.28 0.14
24:0 3.54 0.40 0.54 0.15
Total FA 147.11 185.91 220.96 110.69
EPA + DHA 1.74 0.21 0.28 0.93
EPA + DHA + DPA 2.74 0.21 0.45 1.16
SFA 64.02 34.52 37.66 16.77
MUFA 35.09 60.13 78.46 55.12
PUFA 48.00 91.26 104.84 38.81
PUFA/SFA 0.75 2.64 2.78 2.31
∑n3PUFA 19.18 9.05 11.66 7.51
∑n6PUFA 28.16 82.12 92.88 31.30
n6/n3PUFA 1.47 9.08 7.97 4.17
# LA, linoleic acid; ALA, α-linolenic acid; CLA, conjugated linolenic acid; ARA, arachidonic acid; EPA, eicosapentaenoic acid; DHA,
docosahexaenoic acid; DPA, docosapentaenoic acid; ΣSFA, total saturated fatty acids; FA, fatty acid; ΣMUFA, total monounsaturated fatty
acids; and total polyunsaturated fatty acids (ΣPUFA); ∑SFA is the sum of 14:0, 15:0, 16:0, 17:0, 18:0, 20:0, 21:0, 22:0, 23:0, 24:0; ∑MUFA is
the sum of 14:1, 16:1, 17:1n-8 + a17:0, 18:1, 19:1, 20:1, 22:1, 23:1, 24:1; ∑PUFA is the sum of 18:4n-3, 18:3n-6, 18:2n-6, 18:3n-3, 20:3, 20:4n-3,
20:4n-6, 20:5n-3, 20:3n-6, 20:2n-6, 22:6n-3, 22:5n-3, 22:5n-6, 22:4n-6; ∑n-3 LC-PUFA is the sum of 18:3n-3, 18:4n-3, 20:4n-3, 20:5n-3, 22:6n-3,
22:5n-3; ∑n-6 PUFA is the sum of 18:2n-6, 18:3n-6, 20:4n-6, 20:3n-6, 20:2n-6, 22:5n-6, 22:4n-6.
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Table 3. Fatty acid profile (mg/100 g) of Longissimus thoracis et lumborum muscle tissue in TAW lambs #.
Fatty Acid Omega-3 Control MSM Whole Grain p-Value
13:0 0.05 ± 0.11 0.03 ± 0.04 0.00 ± 0.00 0.1108
14:1 0.63 ± 0.65 0.31 ± 0.33 0.19 ± 0.34 0.0417
14:0 24.25 ± 18.62 16.80 ± 7.84 14.22 ± 8.06 0.0809
15:1 4.44 ± 2.36 2.26 ± 1.22 1.58 ± 0.85 0.0005
16:0 320.50 ± 182.90 209.83 ± 83.05 169.06 ± 79.43 0.0106
16:1 25.86 ± 17.40 16.93 ± 7.29 14.43 ± 8.57 0.0398
17:1n8c + a17:0 13.83 ± 7.99 9.40 ± 3.68 7.85 ± 3.55 0.0201
17:0 16.85 ± 9.12 10.80 ± 4.08 8.31 ± 3.10 0.0035
18:3n6 1.09 ± 0.38 0.93 ± 0.28 0.71 ± 0.31 0.0116
18:4n-3 0.34 ± 0.28 0.01 ± 0.04 0.03 ± 0.05 0.0006
18:2n-6 (LA) 99.35 ± 25.12 57.06 ± 14.44 46.89 ± 10.66 0.0000
18:3n-3 (ALA) 15.70 ± 5.01 8.76 ± 2.46 6.87 ± 2.64 0.0000
CLA 3.83 ± 2.05 2.65 ± 1.03 1.79 ± 0.93 0.0030
18:0 208.83 ± 119.80 139.11 ± 54.40 99.63 ± 40.82 0.0042
18:1 582.31 ± 364.95 395.67 ± 173.74 305.06 ± 147.93 0.0174
19:1 1.31 ± 0.68 0.89 ± 0.37 0.93 ± 0.51 0.1222
20:4n-6 (ARA) 21.87 ± 8.20 11.26 ± 8.18 4.78 ± 3.64 0.0000
20:5n-3 (EPA) 9.68 ± 3.68 4.25 ± 2.15 2.36 ± 1.01 0.0000
22:3 0.19 ± 0.31 0.21 ± 0.22 0.18 ± 0.23 0.9168
20:3n-6 4.61 ± 1.17 2.10 ± 0.68 1.74 ± 0.58 0.0000
20:4n-3 0.02 ± 0.05 0.10 ± 0.18 0.15 ± 0.24 0.0945
20:2n-6 1.66 ± 0.41 0.52 ± 0.20 0.45 ± 0.29 0.0000
20:0 1.71 ± 1.01 1.15 ± 0.40 0.82 ± 0.37 0.0051
20:1 4.45 ± 2.34 1.71 ± 0.63 1.30 ± 0.68 0.0001
21:5n-3 0.15 ± 0.13 0.14 ± 0.12 0.11 ± 0.12 0.4905
21:0 0.13 ± 0.22 0.04 ± 0.09 0.10 ± 0.14 0.5992
22:5n-6 0.27 ± 0.22 0.26 ± 0.25 0.24 ± 0.11 0.6978
22:6n-3 (DHA) 5.59 ± 1.63 1.85 ± 0.81 1.28 ± 0.67 0.0000
22:4n-6 1.10 ± 0.39 0.93 ± 0.33 0.91 ± 0.25 0.2010
22:5n-3 (DPA) 9.69 ± 3.36 5.48 ± 1.75 4.42 ± 1.25 0.0000
22:0 0.48 ± 0.27 0.34 ± 0.17 0.36 ± 0.43 0.3908
22:1 0.68 ± 0.31 0.52 ± 0.14 0.43 ± 0.21 0.0218
23:1 0.00 ± 0.00 0.00 ± 0.00 0.02 ± 0.05 0.2268
23:0 0.78 ± 0.18 0.52 ± 0.16 0.41 ± 0.09 0.0000
24:1 1.37 ± 0.33 0.66 ± 0.16 0.66 ± 0.24 0.0000
24:0 0.98 ± 0.29 0.61 ± 0.17 0.53 ± 0.25 0.0004
Total FA 1384.60 ± 766.56 904.11 ± 342.20 698.78 ± 307.88 0.0056
EPA + DHA 15.28 ± 5.12 6.11 ± 2.88 3.64 ± 1.49 0.0000
EPA + DHA + DPA 24.97 ± 8.27 11.58 ± 4.54 8.05 ± 2.56 0.0000
∑SFA 579.40 ± 333.52 381.87 ± 149.39 295.27 ± 131.95 0.0079
∑MUFA 630.23 ± 393.61 425.92 ± 185.28 330.79 ± 161.51 0.0172
∑PUFA 175.14 ± 47.59 96.53 ± 28.59 72.90 ± 19.03 0.0000
PUFA/SFA 0.36 ± 0.14 0.29 ± 0.12 0.27 ± 0.10 0.1210
∑n-3PUFA 41.36 ± 12.83 20.81 ± 6.43 15.38 ± 5.24 0.0000
∑n-6PUFA 133.78 ± 35.37 75.71 ± 22.91 57.51 ± 14.31 0.0000
n-6/n-3PUFA 3.33 ± 0.52 3.72 ± 0.63 3.87 ± 0.65 0.0499
# Abbreviations as in Table 2.
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Table 4. Fatty acid profile (mg/100 g) of the liver in TAW lambs #.
Fatty Acid Omega-3 Control MSM Whole Grain p-Value
13:0 0.24 ± 0.26 0.16 ± 0.26 0.36 ± 0.50 0.3890
14:1 0.84 ± 0.92 1.45 ± 1.21 0.55 ± 0.86 0.6411
14:0 26.95 ± 8.36 31.22 ± 8.74 40.09 ± 13.89 0.0190
15:1 19.20 ± 6.55 15.49 ± 5.47 18.81 ± 7.39 0.7370
16:0 755.15 ± 151.51 765.95 ± 134.32 906.84 ± 205.56 0.0938
16:1 66.47 ± 18.67 83.97 ± 26.54 89.50 ± 28.94 0.0783
17:1n8c + a17:0 46.43 ± 11.84 62.51 ± 16.78 78.31 ± 25.78 0.0017
17:0 73.54 ± 16.08 76.10 ± 16.51 101.28 ± 26.67 0.0143
18:3n6 9.67 ± 3.17 13.31 ± 4.89 15.45 ± 5.60 0.0160
18:4n-3 6.10 ± 3.34 2.34 ± 2.22 2.15 ± 3.18 0.0098
18:2n-6 (LA) 508.28 ± 68.59 438.04 ± 84.82 570.01 ± 99.23 0.2330
18:3n-3 (ALA) 72.78 ± 18.68 50.46 ± 9.52 58.65 ± 12.48 0.0655
CLA 12.45 ± 2.57 15.13 ± 3.13 18.05 ± 8.47 0.0346
18:0 1050.30 ± 82.46 879.11 ± 139.95 1058.24 ± 190.38 0.9770
18:1 1414.42 ± 210.44 1414.52 ± 268.81 1521.50 ± 345.97 0.4875
19:1 7.25 ± 1.88 8.93 ± 2.98 12.35 ± 3.47 0.0010
20:4n-6 (ARA) 213.71 ± 41.72 310.53 ± 69.00 368.35 ± 71.25 0.0000
20:5n-3 (EPA) 122.60 ± 36.37 40.03 ± 9.65 43.99 ± 10.29 0.0000
22:3 2.08 ± 2.23 6.35 ± 2.14 7.16 ± 1.72 0.0001
20:3n-6 58.65 ± 9.41 33.88 ± 5.74 49.26 ± 16.35 0.1700
20:4n-3 6.07 ± 0.84 5.00 ± 2.59 6.03 ± 1.75 0.9550
20:2n-6 12.96 ± 3.02 6.72 ± 1.79 8.59 ± 1.24 0.0033
20:0 33.42 ± 7.26 19.28 ± 5.06 21.45 ± 3.60 0.0652
20:1 5.02 ± 0.28 6.25 ± 1.61 6.38 ± 1.97 0.0007
21:5n-3 1.58 ± 0.71 3.27 ± 2.79 2.76 ± 2.20 0.2770
21:0 0.37 ± 0.21 0.28 ± 0.29 0.51 ± 0.26 0.2643
22:5n-6 5.23 ± 3.89 17.08 ± 3.63 21.53 ± 5.93 0.0000
22:6n-3 (DHA) 286.77 ± 95.79 116.09 ± 30.92 124.56 ± 30.70 0.0001
22:4n-6 16.44 ± 9.99 39.84 ± 11.41 54.47 ± 11.01 0.0000
22:5n-3 (DPA) 185.12 ± 30.84 133.09 ± 29.99 154.08 ± 24.89 0.0515
22:0 6.78 ± 1.87 2.05 ± 0.87 2.12 ± 0.74 0.0000
22:1 9.76 ± 0.84 8.20 ± 1.11 9.31 ± 1.81 0.5057
23:1 0.56 ± 0.57 0.14 ± 0.22 0.17 ± 0.27 0.0504
23:0 15.48 ± 0.82 16.69 ± 2.77 20.36 ± 4.07 0.0011
24:1 17.44 ± 2.66 11.81 ± 2.62 11.14 ± 1.71 0.0000
24:0 16.10 ± 1.00 15.49 ± 2.52 17.48 ± 2.82 0.2397
Total FA 5085.02 ± 632.20 4650.60 ± 806.74 5421.65 ± 1044.59 0.5016
EPA + DHA 409.37 ± 127.95 156.12 ± 37.43 168.54 ± 35.69 0.0000
EPA + DHA + DPA 594.49 ± 153.14 289.22 ± 63.49 322.62 ± 56.93 0.0002
∑SFA 1972.10 ± 229.59 1814.93 ± 295.51 2179.67 ± 431.38 0.2769
∑MUFA 1593.04 ± 242.26 1604.51 ± 317.62 1736.91 ± 404.01 0.4181
∑PUFA 1519.88 ± 191.39 1231.16 ± 228.83 1505.07 ± 261.64 0.8519
PUFA/SFA 0.77 ± 0.06 0.68 ± 0.06 0.70 ± 0.07 0.0365
∑n-3PUFA 682.48 ± 170.17 356.63 ± 72.64 399.37 ± 68.16 0.0004
∑n-6PUFA 1045.88 ± 117.45 1167.97 ± 233.56 1452.52 ± 275.64 0.0008
n-6/n-3PUFA 1.69 ± 0.83 3.30 ± 0.43 3.66 ± 0.49 0.0000
# Abbreviations as in Table 2.
3.4. Fatty Acid Profile of the Kidney
The fatty acid profile of the kidney is presented in Table 5. Within the n-3 LC-PUFA,
the contents of ALA, EPA, DHA, DPA, EPA + DHA, and EPA + DHA + DPA were greater in
the omega-3 oil diet than in the control and MSM whole grain diets. The overall increase in
the contents of 18:3 n-3 and its long chain metabolites remained statistically significant. A
boxplot of Hochberg’s adjusted multiple comparisons of significant differences between the
treatment groups in kidney fatty acid profiles are depicted in Figure 3, where the omega-3
oil diet maintained a significantly higher fatty acid content than the control and MSM
whole grain diets. However, the control diet had the highest contents of C22:0, C20:2n-6,
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C22:5n-6, C22:4n-6, and n-6/n-3 PUFA ratio, while the MSM whole grain diet led in C20:0
and C21:5n-3 contents.
Table 5. Fatty acid profile (mg/100 g) of the kidney in TAW lambs #.
Fatty Acid Omega-3 Control MSM Whole Grain p-Value
13:0 0.22 ± 0.21 0.16 ± 0.22 0.28 ± 0.22 0.5721
14:1 0.1 ± 0.14 0.05 ± 0.15 0.04 ± 0.07 0.2296
14:0 7 ± 2.29 6.96 ± 2.3 5.42 ± 1.27 0.0886
15:1 5.33 ± 1.39 5.73 ± 1.45 3.72 ± 1.33 0.0217
16:0 317.14 ± 52.86 339.32 ± 63.53 283.75 ± 48.67 0.2055
16:1 10.57 ± 2.87 11.21 ± 2.56 11.39 ± 2.94 0.5105
17:1n8c + a17:0 12.44 ± 1.91 14.29 ± 3.33 12.04 ± 2.77 0.7594
17:0 25.4 ± 3.66 28.7 ± 7.39 23.32 ± 5.09 0.4353
18:3n6 1.75 ± 0.54 1.28 ± 0.28 0.98 ± 0.25 0.0001
18:4n-3 0.00 ± 0.00 0.04 ± 0.12 0.01 ± 0.03 0.7995
18:2n-6 (LA) 281.42 ± 66.94 280.63 ± 73.32 249.57 ± 56.92 0.2849
18:3n-3 (ALA) 12.43 ± 3.02 8.4 ± 1.62 7.63 ± 1.61 0.0001
CLA 3.5 ± 0.82 3.78 ± 0.85 3.11 ± 1.14 0.3653
18:0 351.69 ± 51.59 327.73 ± 62.89 279.14 ± 47.83 0.0054
18:1 320.27 ± 53.92 314.51 ± 56.7 293.23 ± 58.49 0.2854
19:1 2.17 ± 0.44 3.84 ± 1.28 2.9 ± 1.01 0.1645
20:4n-6 (ARA) 169.81 ± 27.05 246.86 ± 57.97 209.05 ± 37.93 0.0940
20:5n-3 (EPA) 69.1 ± 17.67 16.87 ± 4.66 16.57 ± 2.71 0.0000
20:3 1.1 ± 0.62 2.98 ± 0.75 3.06 ± 1.12 0.0001
20:3n-6 19.6 ± 3.26 17.41 ± 5.3 12.88 ± 3.59 0.0010
20:4n-3 1.95 ± 0.45 1.91 ± 0.92 2.54 ± 1.71 0.2627
20:2n-6 7.9 ± 1.65 8.77 ± 2.68 6.62 ± 2.3 0.2320
20:0 5.35 ± 1.12 5.84 ± 1.13 4.91 ± 0.85 0.3655
20:1 11.88 ± 2.14 9.14 ± 2.2 8.52 ± 2.19 0.0020
21:5n-3 0.48 ± 0.13 0.99 ± 0.38 1.04 ± 0.35 0.0006
21:0 0.69 ± 0.13 0.82 ± 0.16 0.65 ± 0.13 0.5464
22:5n-6 0.44 ± 0.49 3.03 ± 0.73 2.33 ± 0.62 0.0003
22:6n-3 (DHA) 58.76 ± 10.76 25.17 ± 5.59 25.3 ± 5.21 0.0000
22:4n-6 3.52 ± 0.76 15.04 ± 5.17 9.88 ± 3.32 0.0133
22:5n-3 (DPA) 43.39 ± 6.14 33.76 ± 8.04 29.14 ± 4.96 0.0000
22:0 35.02 ± 6.6 36.52 ± 8.02 29.06 ± 5.3 0.0000
22:1 9.01 ± 1.71 5.12 ± 2.16 3.62 ± 1.08 0.0659
23:1 0.56 ± 0.23 0.96 ± 0.34 0.8 ± 0.28 0.1012
23:0 8.84 ± 1.35 9.96 ± 1.97 7.94 ± 1.71 0.2826
24:1 30.55 ± 5.54 33.12 ± 7.47 32.73 ± 7.26 0.4763
24:0 34.42 ± 5.47 37.53 ± 7.62 31.21 ± 6.79 0.3120
Total FA 1499.2 ± 208.97 1515.42 ± 308.98 1322.14 ± 193.73 0.1155
EPA + DHA 127.86 ± 26.2 42.04 ± 9.14 41.87 ± 7.28 0.0000
EPA + DHA + DPA 171.26 ± 29.76 75.8 ± 15.82 71.01 ± 10.98 0.0000
∑SFA 439.41 ± 67.09 471.55 ± 89.38 390.25 ± 66.92 0.1743
∑MUFA 385.11 ± 61.94 377.95 ± 69.57 353.22 ± 71.1 0.2933
∑PUFA 674.69 ± 91.83 665.92 ± 156.17 578.66 ± 79.86 0.0698
PUFA/SFA 1.54 ± 0.13 1.4 ± 0.12 1.51 ± 0.29 0.7367
∑n-3PUFA 187.22 ± 32.15 90.12 ± 18.16 85.28 ± 13.7 0.0000
∑n-6PUFA 318.13 ± 70.45 329.97 ± 86.61 285.38 ± 60.57 0.3264
n-6/n-3PUFA 1.74 ± 0.42 3.65 ± 0.64 3.44 ± 1.14 0.0003
# Abbreviations as in Table 2.
3.5. Fatty Acid Profile of the Heart
Table 6 shows the fatty acid contents of the heart. The hearts from lambs on the
omega-3 oil diet had the highest ALA, EPA, C20:2n-6, EPA + DHA, EPA + DHA + DPA, n-3
LC-PUFA, DHA, and DPA contents and lowest n-6/n-3 PUFA ratio than in the control and
MSM whole grain diets. However, the hearts of lambs fed the control diet had the highest
contents of C23:0, C22:0m and C22:4n-6, while those on the MSM whole grain diet had
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the highest C20:3 and C21:5 n-3 contents. As shown in Figure 4, a boxplot of Hochberg’s
adjusted multiple comparisons of significant differences between the treatment groups
in the heart fatty acid profiles shows that the omega-3 oil diet maintained a significantly
higher EPA, DHA, EPA + DHA, EPA + DHA + DPA, and ∑n-3PUFA content than the
control and MSM whole grain diets, while the control diet had higher C22:4n-6 content
and n-6/n-3 PUFA ratio than both omega-3 oil and MSM whole grain diets.




Figure 3. Boxplots showing the distribution of selected fatty acids composition in the kidney. Each plot tested the mean 
fatty acid in omega-3 versus control, omega-3 versus MSM whole grain and control versus MSM whole grain with 
Hochberg’s adjusted multiple comparisons. *p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns, not significant (p > 0.05). 
3.5. Fatty Acid Profile of the Heart 
Table 6 shows the fatty acid contents of the heart. The hearts from lambs on the 
omega-3 oil diet had the highest ALA, EPA, C20:2n-6, EPA + DHA, EPA + DHA + DPA, 
n-3 LC-PUFA, DHA, and DPA contents and lowest n-6/n-3 PUFA ratio than in the control 
and MSM whole grain diets. However, the hearts of lambs fed the control diet had the 
highest contents of C23:0, C22:0m and C22:4n-6, while those on the MSM whole grain diet 
had the highest C20:3 and C21:5 n-3 contents. As shown in Figure 4, a boxplot of 
Hochberg’s adjusted multiple comparisons of significant differences between the treat-
ment groups in the heart fatty acid profiles shows that the omega-3 oil diet maintained a 
significantly higher EPA, DHA, EPA + DHA, EPA + DHA + DPA, and ∑n-3PUFA content 
than the control and MSM whole grain diets, while the control diet had higher C22:4n-6 
content and n-6/n-3 PUFA ratio than both omega-3 oil and MSM whole grain diets. 
Table 6. Fatty acid profile (mg/100 g) of the heart in TAW lambs #. 
Fatty Acid Omega-3 Control MSM Whole Grain p-Value 
13:0 0.14 ± 0.35 0.02 ± 0.07 0.03 ± 0.1 0.2533 
14:1 0.51 ± 0.35 0.61 ± 0.3 0.36 ± 0.47 0.3935 
14:0 45.97 ± 95.07 13.63 ± 9.65 23.69 ± 32.81 0.3994 
15:1 11.42 ± 20.53 4.75 ± 2.84 6.68 ± 5.79 0.3391 
16:0 539.22 ± 573.68 402.04 ± 132.98 389.7 ± 233.75 0.3616 
16:1 59.06 ± 91.19 34.61 ± 18.23 41.34 ± 35.23 0.4919 
17:1n8c + a17:0 33.28 ± 40.65 21.73 ± 10.42 26.43 ± 18.68 0.5655 
17:0 57.87 ± 82.96 37.03 ± 17.28 41.53 ± 29.75 0.4822 
18:3n6 2.81 ± 1.01 2.55 ± 0.55 2.24 ± 0.57 0.0919 
18:4n-3 0.31 ± 0.46 0.15 ± 0.29 0.06 ± 0.12 0.0823 
18:2n-6 (LA) 543.33 ± 141.44 591.85 ± 100.17 466.72 ± 122.48 0.1901 
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4. Discussion 
A prospective cohort study of men in the USA [45] and a cross-sectional survey of 
Korean adults [46] both reinforced the need to enhance a healthier composition of red 
meat among consumers to minimize the dietary risks of coronary heart disease, cardi-
ometabolic, and cancer mortality burdens. Previous studies [22,47–51] had established 
that the fatty acid profiles of muscles and organs can be modified by dietary supplemen-
tation with n-3 LC-PUFA, leading to higher human health beneficial EPA + DHA + DPA 
and lower n-3/n-6 ratio [52]. It is important to strike a balance between attaining higher 
total PUFA deposition in the muscle and oxidative stability [53] because meat color, fla-
vor, nutritional value, shelf-life, and overall consumer acceptance can be compromised by 
lipid oxidation [54,55]. Therefore, in this study, the time-tested and oxidatively stable 
omega-3 oil infused pellets previously reported in Le et al. [49] were utilized in the com-
parative analysis with non-oil and whole grain pellets. 
The level of incorporation and abundance of both monounsaturated (MUFA) and 
polyunsaturated (PUFA) fatty acids in the muscle is consistent with previously reported 
intramuscular fatty acid compositions [56,57]. A review of pre-clinical and human trials 
with conjugated linoleic acid CLA (C18:2n-6) revealed positive effects on cancer, obesity, 
and atherosclerosis [58,59], and the muscle in the present study had significantly incorpo-
rated levels of CLA and ALA (C18:3n-3). ALA is the precursor for the synthesis of n-3 LC-
PUFA through desaturation and/or chain-elongation by desaturase and elongase enzymes 
[60,61]. In the present study, it was evident that supplementation of lambs with omega-3 
oil-fortified pellets increased the muscle contents of ALA by two-to three-folds, which 
translated into higher contents of EPA + DHA + DPA than in muscles from the control and 
whole grain diets. Furthermore, the high and significant levels of C20:4n-6 in the muscle 
could be a result of LA being subjected to elongation and desaturation by delta-5 and 
delta-6 desaturases and elongase enzymes [62], since all dietary treatments favored de 
Figure 4. Boxpl ts showing the distribution of selected fatt ci s composition in the heart. Each plot test d the mean fatty
acid in omega-3 versus control, mega-3 versus MSM l in, and control ver us SM whole grain with Hochberg’s
adjusted multiple comparisons. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001; ns, not significant (p > 0.05).
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Table 6. Fatty acid profile (mg/100 g) of the heart in TAW lambs #.
Fatty Acid Omega-3 Control MSM Whole Grain p-Value
13:0 0.14 ± 0.35 0.02 ± 0.07 0.03 ± 0.1 0.2533
14:1 0.51 ± 0.35 0.61 ± 0.3 0.36 ± 0.47 0.3935
14:0 45.97 ± 95.07 13.63 ± 9.65 23.69 ± 32.81 0.3994
15:1 11.42 ± 20.53 4.75 ± 2.84 6.68 ± 5.79 0.3391
16:0 539.22 ± 573.68 402.04 ± 132.98 389.7 ± 233.75 0.3616
16:1 59.06 ± 91.19 34.61 ± 18.23 41.34 ± 35.23 0.4919
17:1n8c + a17:0 33.28 ± 40.65 21.73 ± 10.42 26.43 ± 18.68 0.5655
17:0 57.87 ± 82.96 37.03 ± 17.28 41.53 ± 29.75 0.4822
18:3n6 2.81 ± 1.01 2.55 ± 0.55 2.24 ± 0.57 0.0919
18:4n-3 0.31 ± 0.46 0.15 ± 0.29 0.06 ± 0.12 0.0823
18:2n-6 (LA) 543.33 ± 141.44 591.85 ± 100.17 466.72 ± 122.48 0.1901
18:3n-3 (ALA) 31.32 ± 26.24 18.55 ± 7.28 22.03 ± 15.47 0.2636
CLA 709.39 ± 866.87 492.75 ± 233.75 459.86 ± 332.73 0.3144
18:0 862.44 ± 1163.49 557.84 ± 334.03 601.47 ± 462.38 0.4367
18:1 9.67 ± 10.06 6.03 ± 2.24 5.68 ± 3 0.1578
19:1 3.32 ± 3.49 2.59 ± 1.28 3.41 ± 2.54 0.9383
20:4n-6 (ARA) 128.74 ± 35.44 166.3 ± 33.44 143.74 ± 48.1 0.4257
20:5n-3 (EPA) 38.59 ± 11.44 18.01 ± 3.9 14.87 ± 4.96 0.0000
22:3 1.6 ± 0.83 3.05 ± 0.79 2.23 ± 0.62 0.1398
20:3n-6 18.01 ± 4.67 12.78 ± 3.01 9.71 ± 2.57 0.0000
20:4n-3 0.22 ± 0.28 0.48 ± 0.72 0.11 ± 0.24 0.6342
20:2n-6 5.12 ± 2.19 2.45 ± 0.87 1.82 ± 0.6 0.0000
20:0 6.11 ± 8.08 4.76 ± 2.14 4.27 ± 2.66 0.4158
20:1 11.82 ± 10.49 6.45 ± 2.36 5.24 ± 3.19 0.0301
21:5n-3 0.29 ± 0.55 0.62 ± 0.32 0.39 ± 0.26 0.6112
21:0 0.62 ± 0.74 0.48 ± 0.13 0.61 ± 0.46 0.9544
22:5n-6 1.26 ± 0.58 2.49 ± 0.57 2.21 ± 0.64 0.0045
22:6n-3 (DHA) 36.74 ± 9.42 15.37 ± 4.1 11.99 ± 3.73 0.0000
22:4n-6 2.91 ± 0.89 6.06 ± 1.29 5.5 ± 1.16 0.0003
22:5n-3 (DPA) 34.82 ± 9.38 19.03 ± 14.44 23 ± 6.92 0.0301
22:0 2.95 ± 1.25 0.97 ± 0.33 0.69 ± 0.38 0.0000
22:1 4.47 ± 2.07 5.03 ± 1.97 3.72 ± 1.83 0.4011
23:1 0.43 ± 0.28 0.17 ± 0.19 0.02 ± 0.05 0.0000
23:0 4.58 ± 1.46 6.38 ± 1.24 4.43 ± 1.42 0.8409
24:1 10.03 ± 3.11 8.43 ± 1.31 5.59 ± 1.55 0.0000
24:0 4.19 ± 1.24 4.65 ± 1.82 3.72 ± 1.03 0.4712
Total FA 3223.54 ± 3074.77 2470.68 ± 880 2335.08 ± 1176.42 0.3140
EPA + DHA 75.32 ± 20.32 33.38 ± 7.73 26.86 ± 8.05 0.0000
EPA + DHA + DPA 110.14 ± 28.19 52.41 ± 18.48 49.86 ± 14.91 0.0000
∑SFA 1384 ± 1645.79 971.52 ± 396.97 938.25 ± 632.49 0.3409
∑MUFA 983.83 ± 1309.31 633.39 ± 366.3 684.53 ± 519.99 0.4274
∑PUFA 855.71 ± 225.88 865.77 ± 149 712.3 ± 183.06 0.1016
PUFA/SFA 1 ± 0.42 0.98 ± 0.25 0.99 ± 0.48 0.9636
∑n-3PUFA 143.88 ± 41.03 75.26 ± 23.68 74.68 ± 23.06 0.0000
∑n-6PUFA 711.84 ± 189.55 790.5 ± 130.94 637.62 ± 168.09 0.3408
n-6/n-3PUFA 5.01 ± 0.68 11.12 ± 2.43 8.82 ± 1.92 0.0041
# Abbreviations as in Table 2.
4. Discussion
A prospective cohort study of men in the USA [45] and a cross-sectional survey of
Korean adults [46] both reinforced the need to enhance a healthier composition of red meat
among consumers to minimize the dietary risks of coronary heart disease, cardiometabolic,
and cancer mortality burdens. Previous studies [22,47–51] had established that the fatty
acid profiles of muscles and organs can be modified by dietary supplementation with n-3
LC-PUFA, leading to higher human health beneficial EPA + DHA + DPA and lower n-3/n-6
ratio [52]. It is important to strike a balance between attaining higher total PUFA deposition
in the muscle and oxidative stability [53] because meat color, flavor, nutritional value,
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shelf-life, and overall consumer acceptance can be compromised by lipid oxidation [54,55].
Therefore, in this study, the time-tested and oxidatively stable omega-3 oil infused pellets
previously reported in Le et al. [49] were utilized in the comparative analysis with non-oil
and whole grain pellets.
The level of incorporation and abundance of both monounsaturated (MUFA) and
polyunsaturated (PUFA) fatty acids in the muscle is consistent with previously reported
intramuscular fatty acid compositions [56,57]. A review of pre-clinical and human trials
with conjugated linoleic acid CLA (C18:2n-6) revealed positive effects on cancer, obesity,
and atherosclerosis [58,59], and the muscle in the present study had significantly incor-
porated levels of CLA and ALA (C18:3n-3). ALA is the precursor for the synthesis of
n-3 LC-PUFA through desaturation and/or chain-elongation by desaturase and elongase
enzymes [60,61]. In the present study, it was evident that supplementation of lambs with
omega-3 oil-fortified pellets increased the muscle contents of ALA by two-to three-folds,
which translated into higher contents of EPA + DHA + DPA than in muscles from the
control and whole grain diets. Furthermore, the high and significant levels of C20:4n-6
in the muscle could be a result of LA being subjected to elongation and desaturation by
delta-5 and delta-6 desaturases and elongase enzymes [62], since all dietary treatments
favored de novo fatty acid synthesis due to high levels of C18:1 originating from elongation
and desaturation of C16:0 into palmitoleic and C18:0 into oleic acids [63–65]. In terms of
dietary n-6/n-3 PUFA ratio, the human nutrition guidelines recommend an ideal value
of not more than 4 [66], because n-3 PUFA plays an anti-inflammatory role [67], while n-6
PUFA exerts pro-inflammatory effects [68] in asthma and rheumatoid arthritis [69] and
increased risk of cancer [70]. This study clearly demonstrated that supplementing lambs
with omega-3 oil is an excellent nutritional strategy for lowering the n-6/n-3 ratio in the
muscle for a healthier meat.
The liver is responsible for the metabolism, uptake, and dissemination of lipids
through free fatty acids, lipoproteins, and de novo lipogenesis [71]. It plays a role in mito-
chondrial fatty acid β-oxidation and facilitates key catabolic pathways in hepatocytes [71]
and ruminant meat production [72]. In the liver of lambs supplemented with omega-3 oil,
the significantly higher proportions of EPA + DHA + DPA compared to the control diet
equivalent to three-folds of what is obtainable in the kidney and heart (Tables 5 and 6) in
the present study, align with earlier reports [35,49,51]. These figures are well above the
Food Standards of Australia and New Zealand recommendations of 30 mg/100 g as ‘source’
and 60 mg/100 g as ‘good source’ levels [49], and are in agreement with previous studies
showing that the lamb liver is one of the richest sources of EPA + DHA + DPA, comprising
approximately 185 mg/100 g of hepatocytes from omega-3 oil supplemented diet [73]. The
liver levels of CLA were also high in lambs supplemented with omega-3 oil, and given
its reported immuno-modulatory, anti-obesity, and anti-carcinogenic properties [74,75],
the liver could be considered a healthy product. The major synthesis pathway of the CLA
isomer, rumenic acid, in the tissues of ruminants is primarily from the biohydrogenation of
ALA into vaccenic acid (C18:1n-7) catalyzed by reductase enzymes [76,77]. The variation
patterns and ranges in liver fatty acid profiles in the present study were similar to previ-
ously reported findings [78–83]. The liver has also been reported to have a high nutrient
content of essential amino acids, fatty acids, iron, zinc, magnesium, selenium, calcium,
vitamins B1, B6, B12, and folic acid [84,85] and may explain why duck liver attracts a price
premium and is consumed in France [86].
Mashek and Coleman [87] showed that the kidney plays a role in cellular fatty acid
uptake and contributes to metabolism, with strong suggestions that the metabolic demand
for fatty acids is a major driving force governing fatty acid uptake in the kidney. Although
the mechanism is unknown, it appears that converting fatty acids to acyl-CoAs and down-
stream metabolic intermediates increases cellular fatty acid uptake, probably by limiting
efflux [87]. Hagve et al. [88] demonstrated that increasing levels of n-3 fatty acids in mem-
branes affect the uptake and intracellular metabolism of fatty acids as well as membrane
fluidity in the kidney. Evidence from both gain and loss-of-function experiments indicate
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that fatty acid uptake can be modulated by activation at both the plasma membrane and
internal organ sites by intracellular fatty acid binding proteins, and by enzymes in synthetic
or degradative metabolic pathways [87]. In a study of long-chain polyunsaturated fatty
acids metabolism in kidney cells, Liabo et al. [89] argued that only little is known about
the metabolism of fatty acids in the kidney, because it is controversial whether the kidney
possesses the ability to desaturate long-chain fatty acids or kidney cells are dependent
on pre-formed polyunsaturated fatty acids transported from the liver. However, they
concluded that the kidney, at least in part, must obtain its C-20 and C-22 fatty acids from
circulation, while the active delta5-desaturase suggests that pre-formed C-20 fatty acids can
be converted to more unsaturated homologues in the kidney. This could probably explain
the significant increases in the contents of C18:3n-3 and its long chain ALA, EPA, DHA,
and DPA metabolites being greater in the kidney of lambs supplemented with omega-3
oil than in the control and MSM whole grain diets observed in the present study (Table 4
and Figure 3).
Schaap et al. [90] reported that long-chain fatty acids are important fuel molecules
in the heart, because their oxidation in the mitochondria provides the bulk of the energy
required for cardiac functioning. However, the cellular transport of fatty acids in aqueous
solutions is impaired due to low solubility. To circumvent this hurdle, cardiac tissues
contain several fatty acid-binding proteins (FABP) capable of non-covalently binding to
fatty acids, thus facilitating both cellular uptake and intracellular transport of fatty acids.
The majority of fatty acids taken up by the heart seems to pass the sarcolemma through a
carrier-mediated translocation mechanism consisting of one or more membrane-associated
FABP [81]. Perhaps the observed significant differences between the treatment groups in
the heart fatty acid profiles in the present study where the omega-3 oil diet maintained a
significantly higher EPA, DHA, EPA + DHA, EPA + DHA + DPA, and ∑n-3PUFA content
than the control and MSM whole grain diets, could probably be indicative of higher
activities of the FABP in intracellular transport and cellular uptake of long chain fatty acids.
5. Conclusions
This is the first study that evaluated and compared the fatty acid profiles in the tissues
and organs of TAW MARGRA lambs raised in a feedlot production system in response to
dietary supplementation with or without fortification with omega-3 oil. It was primarily
to shed some light on n-3 LC-PUFA metabolism in the Longissimus thoracis et lumborum
muscle, heart, kidney, and liver of lot-fed TAW MARGRA lambs in response to dietary
supplementation with omega-3 oil. The findings suggest that dietary manipulation can
be utilized to improve the fatty acid content and nutritional value of muscle and organs
of TAW MARGRA lambs to meat that more closely meets nutritional guidelines of higher
levels of health-beneficial n-3 LC-PUFA. The data clearly portray the liver, kidney, and
heart of TAW MARGRA lambs with highest contents of the healthiest omega-3 fatty acids
well beyond the FSANZ ‘good source’ levels. Therefore, the hypothesis that fortifying feedlot
pellets with omega-3 oil will enhance the human health beneficial n-3 LC-PUFA composition of
edible lamb muscle tissue and organs holds, and is worthy of acceptance.
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